In conclusion, SE could be a potent RAGE inhibitor for the prevention and treatment of diabetes-associated endothelial dysfunction seen in the early phase of developing atherosclerosis and other RAGE-associated diseases such as inflammation. This evidence concerns the gene AGER and atherosclerosis.